关于癌症幸存者的慢性疼痛治疗的共识声明
Keiko Mamiya1, Hiroki Iida2, Masako Iseki3
1Division of Palliative Medicine, Shinshu Cancer Center, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. keiko@shinshu-u.ac.jp.
Journal of anesthesia
|December 3, 2024
概括
日本疼痛临床学会 (JSPC) 发布了癌症幸存者的慢性疼痛指南,区分了癌症和非癌症疼痛. 非癌症疼痛需要量身定制的管理,以防止阿片类药物过度使用和解决情绪困扰.
科学领域:
- 在瘤学瘤学.
- 疼痛医学 医学 疼痛医学
- 临床实践指南 临床实践指南
背景情况:
- 癌症生存率的提高导致越来越多的癌症幸存者经历慢性疼痛.
- 癌症幸存者的长期疼痛越来越被认为是慢性疼痛,需要专门的管理策略.
- 区分与癌症相关的疼痛和非癌症疼痛对于有效治疗至关重要.
研究的目的:
- 为癌症幸存者提供关于慢性疼痛治疗的共识声明.
- 为指导临床医生在区分和管理不同类型的疼痛在这个人群.
- 强调一种整体的方法,考虑到癌症幸存者的独特心理需求.
主要方法:
- 由日本疼痛临床医师协会 (JSPC) 制订的一致声明.
- 审查目前对癌症幸存者的慢性疼痛的理解和治疗方法.
- 强调区分癌症疼痛与非癌症疼痛.
主要成果:
- 不是癌症幸存者的所有疼痛都是癌症疼痛;非癌症疼痛需要除了阿片类药物和神经阻塞之外的管理.
- 持续的非癌症疼痛应该被归类并作为非癌症慢性疼痛来治疗,以减轻阿片类药物过度使用.
- 幸存者非癌症疼痛的管理必须考虑到心理痛苦和恐惧的复发.
结论:
- 对于癌症幸存者的慢性疼痛管理,需要一个细微的方法.
- 幸存者的非癌症疼痛需要特定的治疗策略,与一般的慢性疼痛不同.
- 未来的教育工具和研讨会计划改善医疗保健专业知识和患者护理.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Analgesia and Pain Management
504
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
504
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


